Connor, Clark & Lunn Investment Management Ltd. Athenex, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$21.8 Billion
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.41 - $0.91 $25,823 - $57,316	-62,985 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.79 - $1.59 $16,044 - $32,291	-20,309 Reduced 24.38%	62,985 $52,000
Q4 2021 Feb 10, 2022	BUY	$1.36 - $2.94 $5,392 - $11,657	3,965 Added 5.0%	83,294 $113,000
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $131,769 - $214,736	44,367 Added 126.9%	79,329 $239,000
Q2 2021 Aug 12, 2021	BUY	$3.71 - $5.13 $129,709 - $179,355	34,962 New	34,962 $162,000

Q3 2020 Nov 12, 2020	SELL	$10.26 - $14.55 $556,799 - $789,613	-54,269 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$7.11 - $13.76 $70,239 - $135,935	-9,879 Reduced 15.4%	54,269 $747,000
Q1 2020 May 13, 2020	BUY	$5.71 - $15.85 $257,652 - $715,199	45,123 Added 237.18%	64,148 $496,000
Q4 2019 Feb 12, 2020	BUY	$9.6 - $17.75 $182,640 - $337,693	19,025 New	19,025 $291,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account